Allergy Treatment Market - Global Outlook & Forecast 2021-2026

Allergy Treatment Market - Global Outlook & Forecast 2021-2026

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Allergy Treatment Market Report

The allergy treatment market by revenue is expected to grow at a CAGR of 6.66% during the period 2020–2026.

The following factors are likely to contribute to the growth of the allergy treatment market by the market during the forecast period

  • Developments In Allergy Immunotherapy
  • Technological Advancements in Medical Devices for Allergy Medication
  • Increasing Risk of Environmental Allergies
  • Rising On-Demand Pharmacies
ALLERGY TREATMENT INDUSTRY INSIGHTS

The increasing risk of environmental allergies, especially in the urban population, is fueling the growth of the allergy treatment industry. Indulging in indoor activities is increasing the incidence of allergies in children. According to the American Academy of Allergy Asthma and Immunology, almost 40% of the global population is sensitized to at least one type of allergen. The global allergy treatment market by type is segmented as Medication, Immunotherapy, and Emergency epinephrine. The medication segment contributed the most, acquiring a 75.46% share of the allergy treatment market.

SNIPPETS
  • Europe and APAC are two of the most rapidly growing regions in the allergy treatment market share, with a CAGR of 7.80% and 8.14%, respectively.
  • There is a high awareness of allergy diseases in the North American population. The allergy treatment industry in North America will grow at a CAGR of 5.77% during the forecast period.
  • The immunotherapy segment is expected to grow faster with a CAGR of 9.46% during the forecast period.
  • The global allergy treatment market by oral is expected to reach USD 16.72 billion by 2026.
  • The global skin allergy treatment market acquired a 14.39% share in 2020.
The study considers the allergy treatment market’s present scenario and its market dynamics for the period 2020−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

ALLERGY TREATMENT MARKET SEGMENTATION

This research report includes a detailed segmentation by
  • Product Type
  • Indication
  • Dosage Form
  • Distribution Channel
  • Geography
SEGMENTATION ANALYSIS
  • In 2020 the global allergy treatment market by medications was valued at USD 21.76 billion. The medications segment mainly dominates allergy treatment. Medications provide relief instant due to which is propelling the demand for allergy medication.
  • The global food allergy market size is expected to reach USD 9.62 billion by 2026. According to the World Allergy Organization, almost 2.5% of the general population is allergic to at least one type of food. Another common food allergy is the peanut allergy, which is increasing rapidly in the global population. According to recent studies in the US population, peanut allergies have almost tripled in the last 20 years.
  • The global allergy treatment market by nasal will grow at a CAGR of 6.81% in the upcoming years. Decongestants along with histamines and corticosteroids are commonly prescribed as a nasal formulation. The rising of nasal allergic diseases is propelling the demand for the treatment of allergies.
  • Retail pharmacies acquired a 59.50% market share of the global allergy treatment market. The direct interaction with the customers, thus having higher customer satisfaction. Outpatient care is another driver for the retail pharmacy. Outpatient care is getting more popular as people are getting more and more aware of their own health.
Market Segmentation by Product Type
  • Medications
  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Immunotherapy
  • Emergency Epinephrine
Market Segmentation by Indication
  • Rhinitis
  • Food Allergy
  • Pollen Allergy
  • Skin Allergy
  • Anaphylaxis
  • Others
Market Segmentation by Dosage Form
  • Oral
  • Nasal
  • Others
Market Segmentation by Distribution Channel
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Sales
GEOGRAPHIC ANALYSIS

North America is the biggest segment in the global allergy treatment market by geography.

The rapid development in industrial growth and urbanization in North America is growing the risk of allergies heavily. There is a high awareness of allergy diseases in the North American population, contributing a high share to this industry across the region. Europe is the second-largest market for allergy treatment products. One of the crucial factors for the growth of allergy treatment is the growing number of companies providing immunotherapies across the region. Europe, almost 45% of the population from the age group 20-45 years old, is prevalent for allergic rhinitis, and the advancements in allergy treatment boost the growth.

Market Segmentation by Geography
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • APAC
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Turkey
INSIGHTS BY VENDORS

The competition in the allergy treatment industry is based on the product type. Holding such situations as exceptional, the medications segment is highly competitive. The immunotherapy market is dominated by Allergy Therapeutics and ALK-Abello, with their new and innovative products. The vendors in the segment are focused on introducing newer products that are distinct and innovative to get an edge over competitors. The immunotherapy industry is growing rapidly, with the number of approvals increasing in the US. The key vendors focusing on innovations and clinical research are the leading drivers for the segment.

Prominent Vendors
  • Sanofi
  • GlaxoSmithKline plc
  • Dermapharm Holding SE
  • Johnson & Johnson
  • ALK-Abello A/S
  • Allergy Therapeutics
  • F. Hoffman-La Roche Ltd
  • Boehringer Ingelheim International GmbH
Other Prominent Vendors
  • Stallergenes Greer
  • Aimmune Therapeutics
  • Bayer AG
  • Perrigo Company plc
  • Alcon
  • AstraZeneca AB
  • LES Labs
  • Viatris Inc
  • Teva Pharmaceutical Industries Ltd
  • Amneal Pharmaceuticals LLC
  • Adamis Pharmaceuticals Corporation
  • Kaleo Inc
KEY QUESTIONS ANSWERED:

1. How big is the Allergy Treatment Market?

2. What are the different product types in the Allergy Treatment market?

3. What are the Distribution Channels in the Allergy Treatment market?

4. Who are the Key Vendors in the market?

5. Which region will have the highest market share in Allergy Treatment?

6. Which is the biggest segment in the global allergy treatment market by geography?

7. What is the major market restraint in the growth of the allergy treatment market?


1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market Segmentation by Product
4.3.2 Market Segmentation by Indication
4.3.3 Market Segmentation by Dosage Form
4.3.4 Market Segmentation by Distribution Channel
4.3.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
8 Market Opportunities & Trends
8.1 Developments in Allergy Immunotherapy
8.2 On-Demand Pharmacy
8.3 Technological Advances in Medical Devices for Allergy Treatment
9 Market Growth Enablers
9.1 Anxiety Related to Food Allergies
9.2 Increasing Risk of Environmental Allergies
9.3 Atopic March
9.4 Genetic Factors in Allergy Diseases
10 Market Restraints
10.1 Improper Use of Medical Devices During Self-Administration
10.2 Non-Compliance of Treatment Regime
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Analysis by Product Type
11.2.2 Analysis by Indication
11.2.3 Analysis by Dosage Form
11.2.4 Analysis by Distribution Channel
11.2.5 Analysis by Geography
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Medications
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Medications: Geography Segmentation
12.3.4 Medications: Product Type Segmentation
12.4 Antihistamines
12.4.1 Market Size & Forecast
12.4.2 Antihistamines: Geography Segmentation
12.5 Decongestants
12.5.1 Market Size & Forecast
12.5.2 Decongestants: Geography Segmentation
12.6 Corticosteroids
12.6.1 Market Size & Forecast
12.6.2 Corticosteroids: Geography Segmentation
12.7 Mast Cell Stabilizers
12.7.1 Market Size & Forecast
12.7.2 Mast Cell Stabilizers: Geographic Segmentation
12.8 Immunotherapy
12.8.1 Market Overview
12.8.2 Market Size & Forecast
12.8.3 Immunotherapy: Geographic Segmentation
12.9 Emergency Epinephrine
12.9.1 Market Overview
12.9.2 Market Size & Forecast
12.9.3 Emergency Epinephrine: Geographic Segmentation
13 Indication
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Rhinitis
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Rhinitis: Geographic Segmentation
13.4 Food Allergy
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Food Allergy: Geographic Segmentation
13.5 Pollen Allergy
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Pollen Allergy: Geographic Segmentation
13.6 Skin Allergy
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.6.3 Skin Allergy: Geographic Segmentation
13.7 Anaphylaxis
13.7.1 Market Overview
13.7.2 Market Size & Forecast
13.7.3 Anaphylaxis: Geographic Segmentation
13.8 Others
13.8.1 Market Overview
13.8.2 Market Size & Forecast
13.8.3 Others: Geographic Segmentation
14 Dosage Form
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Oral
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Oral: Geographic Segmentation
14.4 Nasal
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Nasal: Geographic Segmentation
14.5 Others
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Others: Geography Segmentation
15 Distribution Channel
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Retail Pharmacy
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Retail Pharmacy: Geographic Segmentation
15.4 Hospital Pharmacy
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Hospital Pharmacy: Geographic Segmentation
15.5 Online Sales
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.5.3 Online Sales: Geographic Segmentation
16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview
17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.2.1 North America: Product Type Segmentation
17.2.2 North America: Indication Segmentation
17.2.3 North America: Dosage Form Segmentation
17.2.4 North America: Distribution Channel Segmentation
17.3 Key Countries
17.3.1 US: Market Size & Forecast
17.3.2 Canada: Market Size & Forecast
18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.2.1 Europe: Product Segmentation
18.2.2 Europe: Indication Segmentation
18.2.3 Europe: Dosage Form Segmentation
18.2.4 Europe: Distribution Channel Segmentation
18.3 Key Countries
18.3.1 Germany: Market Size & Forecast
18.3.2 UK: Market Size & Forecast
18.3.3 France: Market Size & Forecast
18.3.4 Italy: Market Size & Forecast
18.3.5 Spain: Market Size & Forecast
19 APAC
19.1 Market Overview
19.2 Market Size & Forecast
19.2.1 APAC: Product Type Segmentation
19.2.2 APAC: Indication Segmentation
19.2.3 APAC: Dosage Form Segmentation
19.2.4 APAC: Distribution Channel Segmentation
19.3 Key Countries
19.3.1 China: Market Size & Forecast
19.3.2 Japan: Market Size & Forecast
19.3.3 India: Market Size & Forecast
19.3.4 Australia: Market Size & Forecast
19.3.5 South Korea: Middle East & Forecast
20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.2.1 Latin America: Product Type Segmentation
20.2.2 Latin America: Indication Segmentation
20.2.3 Latin America: Dosage Form Segmentation
20.2.4 Latin America: Distribution Channel Segmentation
20.3 Key Countries
20.3.1 Brazil: Market Size & Forecast
20.3.2 Mexico: Market Size & Forecast
20.3.3 Argentina: Market Size & Forecast
21 Middle East & Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.2.1 Middle East & Africa: Product Type Segmentation
21.2.2 Middle East & Africa: Indication Segmentation
21.2.3 Middle East & Africa: Dosage Form Segmentation
21.2.4 Middle East & Africa: Distribution Channel Segmentation
21.3 Key Countries
21.3.1 South Africa: Market Size & Forecast
21.3.2 Saudi Arabia: Market Size & Forecast
21.3.3 Turkey: Market Size & Forecast
22 Competitive Landscape
22.1 Competition Overview
22.2 Market Share Analysis
22.2.1 Sanofi
22.2.2 GlaxoSmithKline
22.2.3 Dermapharm Holding
22.2.4 Johnson & Johnson
22.2.5 ALK-Abello A/S
22.2.6 Allergy Therapeutics
22.2.7 F. Hoffman-La Roche
22.2.8 Boehringer Ingelheim International
23 Key Company Profiles
23.1 Sanofi
23.1.1 Business Overview
23.1.2 Sanofi in Allergy Treatment Market
23.1.3 Product Offerings
23.1.4 Key Strategies
23.1.5 Key Strengths
23.1.6 Key Opportunities
23.2 Glaxosmithkline
23.2.1 Business Overview
23.2.2 GlaxoSmithKline plc in Allergy Treatment Market
23.2.3 Product Offerings
23.2.4 Key Strategies
23.2.5 Key Strengths
23.2.6 Key Opportunities
23.3 Dermapharm Holding SE
23.3.1 Business Overview
23.3.2 Dermapharm Holding in Allergy Treatment Market
23.3.3 Product Offerings
23.3.4 Key Strategies
23.3.5 Key Strengths
23.3.6 Key Opportunities
23.4 Johnson & Johnson
23.4.1 Business Overview
23.4.2 Johnson & Johnson in Allergy Treatment Market
23.4.3 Product Offerings
23.4.4 Key Strategies
23.4.5 Key Strengths
23.4.6 Key Opportunities
23.5 ALK-Abelló
23.5.1 Business Overview
23.5.2 ALK- Abelló in Allergy Treatment Market
23.5.3 Product Offerings
23.5.4 Key Strategies
23.5.5 Key Strengths
23.5.6 Key Opportunities
23.6 Allergy Therapeutics
23.6.1 Business Overview
23.6.2 Allergy Therapeutics in Allergy Treatment Market
23.6.3 Product Offerings
23.6.4 Key Strategies
23.6.5 Key Strengths
23.6.6 Key Opportunities
23.7 F. Hoffmann-La Roche Ltd
23.7.1 Business Overview
23.7.2 F. Hoffmann-La Roche in Allergy Treatment Market
23.7.3 Product Offerings
23.7.4 Key Strategies
23.7.5 Key Strengths
23.7.6 Key Opportunities
23.8 Boehringer Ingelheim International
23.8.1 Business Overview
23.8.2 Boehringer Ingelheim International in Allergy Treatment Market
23.8.3 Product Offerings
23.8.4 Key Strategies
23.8.5 Key Strengths
23.8.6 Key Opportunities
24 Other Prominent Vendors
24.1 Stallergens Greer
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 Aimmune Therapeutics
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 Bayer AG
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 Perrigo Company
24.4.1 Business Overview
24.4.2 Product Offerings
24.5 Alcon
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 Astrazeneca AB
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 LES Labs
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 Viatris
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 Teva Pharmaceutical Industries
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 Amneal Pharmaceuticals
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 Adamis Pharmaceuticals
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 Kaleo
24.12.1 Business Overview
24.12.2 Product Offerings
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
26 Quantitative Summary
26.1 Market by Product Type
26.1.1 North America: Product Type Segmentation
26.1.2 Europe: Product Type Segmentation
26.1.3 APAC: Product Type Segmentation
26.1.4 Latin America: Product Type Segmentation
26.1.5 Middle East & Africa: Product Type Segmentation
26.2 Market by Indication
26.2.1 North America: Indication Segmentation
26.2.2 Europe: Indication Segmentation
26.2.3 APAC: Indication Segmentation
26.2.4 Latin America: Indication Segmentation
26.2.5 Middle East & Africa: Indication Segmentation
26.3 Market by Dosage Form
26.3.1 North America: Dosage Form Segmentation
26.3.2 Europe: Dosage Form Segmentation
26.3.3 APAC: Dosage Form Segmentation
26.3.4 Latin America: Dosage Form Segmentation
26.3.5 Middle East & Africa: Dosage Form Segmentation
26.4 Market by Distribution Channel
26.4.1 North America: Distribution Channel Segmentation
26.4.2 Europe: Distribution Channel Segmentation
26.4.3 APAC: Distribution Channel Segmentation
26.4.4 Latin America: Distribution Channel Segmentation
26.4.5 Middle East & Africa: Distribution Channel Segmentation
26.5 Market by Geography
26.5.1 Medication: Geography Segmentation
26.5.2 Immunotherapy: Geography Segmentation
26.5.3 Emergency Epinephrine: Geography Segmentation
26.5.4 Rhinitis: Geography Segmentation
26.5.5 Food Allergy: Geography Segmentation
26.5.6 Pollen Allergy: Geography Segmentation
26.5.7 Skin Allergy: Geography Segmentation
26.5.8 Anaphylaxis: Geography Segmentation
26.5.9 Others: Geography Segmentation
26.5.10 Oral: Geography Segmentation
26.5.11 Nasal: Geography Segmentation
26.5.12 Others: Geography Segmentation
26.5.13 Retail Pharmacy: Geography Segmentation
26.5.14 Hospital Pharmacy: Geography Segmentation
26.5.15 Online Sales: Geography Segmentation
27 Appendix
27.1 Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook